Post
medscape.com
did:plc:qvi6kr6qftapseinw7yfnaik
Camrelizumab plus concurrent capecitabine and radiotherapy (combination treatment) improved overall survival (OS) and recurrence-free survival in patients with resectable extrahepatic cholangiocarcinoma (EHC) and gallbladder cancer. http://ms.spr.ly/63329s6BKX
2025-07-16T17:00:02.837Z